Features & Benefits
- The most typical SSRI drug approved in 2011
- High effectiveness and safety
- Has a unique pharmacological feature such as alosteric effect
- Includes clinical trial results abroad and in Japan
- Also includes a comparison of efficacy and safety
- It covers the characteristics of escalopram